Jansen's vaccine should not be given to people with history of capillary leak

The European Medicine Agency (EMA) advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome.

EMA’s safety committee ( PRAC ) has recommended that people who have previously had capillary leak syndrome must not be vaccinated with  COVID-19 Vaccine Janssen . The Committee also recommended that capillary leak syndrome should be added to the  product information  as a new side effect of the vaccine, together with a warning to raise awareness among healthcare professionals and patients of this risk.

www.ema.europa.eu/en/news/ema-advises-against-use-covid-19-vaccine-janssen-people-history-capillary-leak-syndrome